These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 24863946)
1. No evidence of correlation between p53 codon 72 G > C gene polymorphism and cancer risk in Indian population: a meta-analysis. Mandal RK; Yadav SS; Panda AK Tumour Biol; 2014 Sep; 35(9):8607-13. PubMed ID: 24863946 [TBL] [Abstract][Full Text] [Related]
2. Effect of TP53 rs1042522 on the susceptibility of patients to oral squamous cell carcinoma and oral leukoplakia: a meta-analysis. Sun Z; Gao W; Cui JT BMC Oral Health; 2018 Aug; 18(1):143. PubMed ID: 30126398 [TBL] [Abstract][Full Text] [Related]
3. Association of TP53 rs1042522 with cervical cancer in the sub-Saharan African population: a meta-analysis. Kamiza AB; Kamiza S; Singini MG; Mathew CG Trop Med Int Health; 2020 Jun; 25(6):666-672. PubMed ID: 32233050 [TBL] [Abstract][Full Text] [Related]
4. P53 codon 72 polymorphism contributes to breast cancer risk: a meta-analysis based on 39 case-control studies. Zhang Z; Wang M; Wu D; Wang M; Tong N; Tian Y; Zhang Z Breast Cancer Res Treat; 2010 Apr; 120(2):509-17. PubMed ID: 19629678 [TBL] [Abstract][Full Text] [Related]
5. Evaluating the association between p53 codon 72 Arg>pro polymorphism and risk of ovary cancer: a meta-analysis. Alqumber MA; Akhter N; Haque S; Panda AK; Mandal RK PLoS One; 2014; 9(4):e94874. PubMed ID: 24747975 [TBL] [Abstract][Full Text] [Related]
6. Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies. Li JF; Zheng EQ; Xie M Gene; 2019 Feb; 685():143-148. PubMed ID: 30403964 [TBL] [Abstract][Full Text] [Related]
7. p.Arg72Pro polymorphism of P53 and breast cancer risk: a meta-analysis of case-control studies. Diakite B; Kassogue Y; Dolo G; Wang J; Neuschler E; Kassogue O; Keita ML; Traore CB; Kamate B; Dembele E; Nadifi S; Murphy RL; Doumbia S; Hou L; Maiga M BMC Med Genet; 2020 Oct; 21(1):206. PubMed ID: 33076844 [TBL] [Abstract][Full Text] [Related]
8. No correlation between TIMP2 -418 G>C polymorphism and increased risk of cancer: evidence from a meta-analysis. Mandal RK; Akhter N; Haque S; Panda AK; Mittal RD; Alqumber MA PLoS One; 2014; 9(8):e88184. PubMed ID: 25136829 [TBL] [Abstract][Full Text] [Related]
9. P53 codon 72 polymorphism and lung cancer risk: evidence from 27,958 subjects. Zhou C; Chen H; Wang A Tumour Biol; 2013 Oct; 34(5):2961-9. PubMed ID: 23715779 [TBL] [Abstract][Full Text] [Related]
10. [Association of murine double minute 2 and P53 polymorphisms with breast cancer susceptibility]. Wang ML; Xu YX; Qian J; Wang FH Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Feb; 47(2):124-8. PubMed ID: 23719102 [TBL] [Abstract][Full Text] [Related]
11. MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis. Wan Y; Wu W; Yin Z; Guan P; Zhou B BMC Cancer; 2011 May; 11():208. PubMed ID: 21619694 [TBL] [Abstract][Full Text] [Related]
12. Association between the TP53BP1 rs2602141 A/C polymorphism and cancer risk: a systematic review and meta-analysis. Liu L; Zhang D; Jiao JH; Wang Y; Wu JY; Huang DS Asian Pac J Cancer Prev; 2014; 15(6):2917-22. PubMed ID: 24761925 [TBL] [Abstract][Full Text] [Related]
13. Association study between the TP53 Rs1042522G/C polymorphism and susceptibility to systemic lupus erythematosus in a Chinese Han population. Yang J; Zhu JM; Wu S; Li J; Wang MR; Wang TT; Lu YW Rheumatol Int; 2017 Apr; 37(4):523-529. PubMed ID: 28184992 [TBL] [Abstract][Full Text] [Related]
14. No Evidence of Association of the Arg72Pro p53 Gene Polymorphism with Cancer Risk in the Saudi Population: a Meta-Analysis. Irshad M; Mandal RK; Al-Drees A; Khalil MS; Abdulghani HM Asian Pac J Cancer Prev; 2015; 16(14):5663-7. PubMed ID: 26320432 [TBL] [Abstract][Full Text] [Related]
15. The roles of ADIPOQ rs266729 and MTNR1B rs10830963 polymorphisms in patients with gestational diabetes mellitus: A meta-analysis. Bai Y; Tang L; Li L; Li L Gene; 2020 Mar; 730():144302. PubMed ID: 31884106 [TBL] [Abstract][Full Text] [Related]
16. Association of rs2233678 and rs2233679 polymorphisms in the PIN1 gene with cancer risk: a meta-analysis. Zhenzhen L; Ning S; Xianghua L Tumour Biol; 2014 Jan; 35(1):433-40. PubMed ID: 23982872 [TBL] [Abstract][Full Text] [Related]
17. Association between rs20417 polymorphism in cyclooxygenase-2 and gastric cancer susceptibility: Evidence from15 case-control studies. Chen S; Chen L; Tan Y; Wang J Medicine (Baltimore); 2019 May; 98(18):e15468. PubMed ID: 31045826 [TBL] [Abstract][Full Text] [Related]
18. Association between the P53 codon 72 polymorphism and nasopharyngeal cancer risk. Cai K; Wang Y; Zhao X; Bao X Tumour Biol; 2014 Mar; 35(3):1891-7. PubMed ID: 24114013 [TBL] [Abstract][Full Text] [Related]
19. Association between p53 Arg72Pro polymorphism and thyroid cancer risk: a meta-analysis. Wu B; Guo D; Guo Y Tumour Biol; 2014 Jan; 35(1):561-5. PubMed ID: 24037912 [TBL] [Abstract][Full Text] [Related]
20. The association between IL-1 family gene polymorphisms and colorectal cancer: A meta-analysis. Liu L; Zhai Z; Wang D; Ding Y; Chen X; Wang Q; Shu Z; Wu M; Chen L; He X; Fan D; Pan F; Xing M Gene; 2021 Feb; 769():145187. PubMed ID: 32998046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]